Skip to main content
Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

Fig. 6

Extracellular a IFN-γ and b IL-4 levels elicited by hexavalent recombinant protein mixture (+) Montanide ISA 50 V and control groups. The red bars represent IFN-γ response and the green bars, IL-4 response. Each bar represents the mean ± SD value of IFN-γ and IL-4 responses of 3 mice from each group. Each bar represents the mean ± SD value of IFN-γ and IL-4 responses of 3 mice from each group. Single cell suspensions were stimulated with rH2, rA4, rE4, rD6, rE6, and rH6 recombinant proteins with a final concentration of 100 μg/ml. In figure, *** represent P ≤ 0.001 and * represent P ≤ 0.05

Back to article page